Related Experiment Videos
[Juvenile monomelic amyotrophy: Hirayama disease]
W Drozdowski1, E Baniukiewicz, M Lewonowska
1Kliniki Neurologicznej AM, Białymstoku.
Neurologia I Neurochirurgia Polska
|December 29, 1998
Summary
Juvenile monomelic amyotrophy, a rare disorder causing unilateral limb weakness, presents biphasic progression. Findings suggest it may be a benign variant of spinal muscular atrophy.
Area of Science:
- Neurology
- Genetics
Background:
- Juvenile monomelic amyotrophy (JMA) is a rare neuromuscular disorder characterized by unilateral limb weakness and muscular atrophy.
- This condition is exceptionally rare outside of Japan, making its diagnosis and understanding challenging in other populations.
Observation:
- Three patients presented with unilateral upper limb weakness and muscular atrophy, with two exhibiting distal and one proximal involvement.
- Disease onset occurred between 18 and 35 years of age, followed by a biphasic course: initial progression for 1-3 years, then stabilization for 4-24 years.
Findings:
- Laboratory investigations and electromyography (EMG) confirmed neurogenic involvement with spinal features, even in clinically unaffected muscles.
- These findings support the hypothesis that JMA could represent a benign variant of spinal muscular atrophy (SMA).
Implications:
- This study expands the understanding of JMA's clinical presentation and diagnostic markers.
- Identifying JMA as a potential SMA variant could influence diagnostic criteria and therapeutic strategies for rare motor neuron diseases.